US Physical Therapy (NYSE: USPH) reported earnings on May 9. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), US Physical Therapy beat slightly on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue grew slightly. GAAP earnings per share dropped significantly.

Margins dropped across the board.

Revenue details
US Physical Therapy tallied revenue of $63.1 million. The six analysts polled by S&P Capital IQ foresaw revenue of $62.3 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.31. The six earnings estimates compiled by S&P Capital IQ predicted $0.33 per share. GAAP EPS of $0.31 for Q1 were 18% lower than the prior-year quarter's $0.38 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 23.7%, 260 basis points worse than the prior-year quarter. Operating margin was 13.2%, 290 basis points worse than the prior-year quarter. Net margin was 6.0%, 130 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $65.6 million. On the bottom line, the average EPS estimate is $0.41.

Next year's average estimate for revenue is $258.5 million. The average EPS estimate is $1.54.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 236 members out of 240 rating the stock outperform, and four members rating it underperform. Among 80 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 79 give US Physical Therapy a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on US Physical Therapy is outperform, with an average price target of $29.50.

Is US Physical Therapy the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.